AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ASE Technology Holding Co., Ltd.

Foreign Filer Report Oct 26, 2018

Preview not available for this file type.

Download Source File

6-K 1 dp97418_6k.htm FORM 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

October 26, 2018

| Commission
File Number 001-16125 |
| --- |
| ASE Technology
Holding Co., Ltd. |
| (Translation of registrant’s name into English) |
| 26
Chin Third Road Nantze
Export Processing Zone Kaoshiung,
Taiwan Republic
of China |
| (Address
of principal executive offices) |

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Field: Page; Sequence: 1

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

/s/ Joseph Tung
Name: Joseph Tung
Title: Chief Financial Officer

Field: Page; Sequence: 2

Field: /Page

Below is the English version of our TWSE MOPS filings on October 26, 2018.

SEQ_NO: 1

Date of announcement: 2018/10/26

Time of announcement: 18:07:38

Subject: Securities and Futures Investors Protection Center filed a civil action against the Company and the director of Company’s Board of Directors

Date of events: 2018/10/26

To which item it meets: paragraph 2

Statement:

  1. Parties to the legal matter: The Company and Company’s director, Mr. Tien Wu

  2. Name of the court or disposing agency: Taiwan Ciaotou District Court

  3. Reference/case numbers of relevant documents: Year 107 Sen-Jin Tze No. 3

  4. Date of occurrence of the event: 2018/10/26

  5. Background and circumstances of the matter (including the property/subject matter under dispute): Securities and Futures Investors Protection Center filed a civil lawsuit in relation to the dismissal of the duty of the appointed Board of Director of the Company, Mr. Tien Wu, in accordance with Paragraph 2 of Section1 of Article 10-1 of Securities Investor and Futures Trader Protection Act.

  6. Course and progression of handling of the matter: The Company will proceed with these matters and proceedings in compliance with applicable laws and regulations in order to protect the rights of the Company and its shareholders, as well as protect the legitimate interest of the defendant.

  7. Effect on company finances and business and estimated monetary amount of the effect: The finance and business operation of the Company remain unaffected.

  8. Countermeasures and status of amelioration: N/A

  9. Any other matters that need to be specified: N/A

Field: Page; Sequence: 3; Options: Last

Field: /Page

Talk to a Data Expert

Have a question? We'll get back to you promptly.